A combination of lithium and valproic acid showed superior effects on motor dysfunction and disease progression in mouse ALS model by inhibiting GSK3β compared to lithium and valproic acid when used alone [32]. This evidence concerns the gene GSK3B and amyotrophic lateral sclerosis.